Newcastle University

I have always been interested in science. After completing Biotechnology degree at the University of New South Wales in Australia, I worked as a research assistant in the Department of Haematology at the Royal Prince Alfred Hospital, Sydney. It was here, working on a Multiple Myeloma trial, that my career in clinical research began. After travelling around the world and deciding to stay put in Newcastle upon Tyne, I picked up where I left off and began working as a Data Manager at the Clinical Research Facility, RVI Hospital. This was soon followed by three years as a Clinical Trial Coordinator at the Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, where I was able to work in oncology clinical research again. Finally, I have now moved onto the role of Trial Manager at the Newcastle Clinical Trials Unit at the Institute of Health and Society. I feel that I now have a deeper understanding of how things work within clinical research and clinical trials as I have experience of multiple roles, from lab-based through to trial management. Too keep me extra busy (& to gain more experience of course!) I am currently completing my final year of a MSc in Clinical Research, where I have developed and am now running my own research study.

Roles and Responsibilities 

Trial Management

CONSERVE - A feasibility study for a multicentre randomised controlled trial to compare surgery (partial nephrectomy) with needle ablation techniques (radiofrequency ablation/cryotherapy) for the treatment of people with small renal masses (4cm).

Biomarker based diagnosis of ventilator associated pneumonia (VAP): a multicentre validation study.

Developmental Clinical Studies: Does GM-CSF restore effective neutrophil function in critically ill patients.

Qualifications

BSc (Hons) (Biotechnology), University of New South Wales, Kensington, Australia

Post Graduate Diploma in Clinical Research - Newcastle University, Newcastle upon Tyne, UK (currently studying towards Masters in Clinical Research) 

Memberships

Registered Member of the Institute of Clinical Research

Member of the NIHR Trial Managers Network 

• Ho PJ, Tay C, Sze DMY, Jeffels M, Brown R, Gibson J, Joshua DE. [Abstract] Cyclin D1 over-expression in myeloma does not affect survival, while increased MMSET expression may be associated with a favourable prognostic effect. In: Proceedings of the Haematology Society of Australia and New Zealand. 2003, Perth, Australia: Haematology Society of Australia and New Zealand.